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Introduction
The delayed, ineffective management of acute ischemic
stroke result in high rates of morbidity and mortality. For
patients with acute ischemic stroke who present with serious
neurologic symptoms on admission or continue to
deteriorate neurologically due to total occlusion despite
maximal medical treatment, an effective intervention to
improve their neurologic symptoms and clinical outcome has
not yet been established. Intravenous tissue plasminogen
activator (t-PA) has been approved for the treatment of acute
ischemic stroke within 3 hours after symptoms onset by the
United States Food and Drug Administration (FDA).20)
Drawbacks associated with intravenous t-PA thrombolysis
include the fact that most patients are not seen within 3
hours, patients with baseline National Institutes of Health
Stroke Scale (NIHSS) scores of 10 or greater do not fare as
well as those with baseline scores of less than 10.1)
Additionally, only 8% of patients with internal carotid artery
(ICA) occlusion receiving intravenous t-PA treatment have
shown early recanalization.4)22) Recently, intra-arterial
thrombolysis has been demonstrated to extend the time
window for the treatment of acute ischemic stroke to 6 hours
but has not been approved by the FDA.7) During the first
hours and days after a stroke, the risk of reocclusion or
recurrent arterio-arterial embolism remains. Alternative
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treatment for acute ischemic stroke patients includes
endovascular mechanical revascularization.8) In acute
atherothrombotic occlusions with underlying stenosis,
mechanical thrombolysis had a low recanalization rate and
reocclusion at initial recanlization site. For patients with
acute ischemic stroke who fail intra-arterial thrombolysis
and mechanical clot disruption, there are few options. In the
case of atherothrombotic occlusion, mechanical
thrombolysis with stent angioplasty may be necessary to
decrease underlying chronic vessel stenosis. We report a
retrospective study to investigate feasibility and outcome of
endovascular stent angioplasty after failed intra-arterial
pharmacological and mechanical thrombolysis for acute
ischemic stroke at our institution. 
Patients and Methods
1. Patients
From January 2002 to July 2005 at one cerebrovascular
center, we identified 9 patients who underwent stent
angioplasty immediately after failed pharmacologic and/or
mechanical thrombolysis in the setting of an acute ischemic
stroke as defined by clinical, radiological findings at
presentation. Clinical and radiographic data included the
following: demographic information, National Institutes of
Health Stroke Scale (NIHSS) score before endovascular
procedures, time to treatment, location of occlusion,
treatment before stenting including pharmacological and
mechanical thrombolysis, and degree of stenosis after
thrombolysis. Poststenting angiographic results were by
degree of stenosis after stenting. Complications felt to be a
result of the procedure were recorded. NIHSS score at the
time of discharge was also recorded. 
2. Techniques of Stent Placement Procedure
A transfemoral approach was used to performed
diagnostic cerebral angiography with a standard 5-French
(Fr) catheter. Digital subtraction angiography of the
ipsilateral and contralateral common carotid arteries and of
the vertebral artery was performed to demonstrate the
occlusion site and to assess potential collateral routes. After
complete occlusion was demonstrated, the diagnostic
catheter was exchanged for a 6-Fr guide catheter that was
placed over a 0.038-inch diameter exchange length wire.
Microcatheters and microwires of different dimensions were
navigated through the guide catheter to access the site of
occlusion. Before crossing the occlusion, the patients were
given intravenous heparin for systemic anticoagulant at a
dose of 60 units per kg body weight or 30 units per kg body
weight if intravenous thrombolytic agents had been
administered. A loading dose (0.4 ug/kg/min) and
maintenance dose (0.1 ug/kg/min) of tirofiban was
administered intravenously to three patients at the discretion
of the physician performing the procedure. Through the
microcatheter, intra-arterial thrombolytic therapy was
performed with urokinase (500,000 units), t-PA (up to 20
mg) or abciximab (up to 4 units). Mechanical thrombolysis
was attempted with balloon angioplasty and the
microcatheter wire. After failure of pharmacological and/or
mechanical thrombolysis, angioplasty with stent placement
was considered especially in case with the underlying severe
vessel stenosis and atherothrombotic occlusion. 
For the performance of stent angioplasty, a 0.014-inch
exchange length microwire was maintained distal to the
vessel occlusion, and stent sized to the target vessel diameter
were navigated to the occlusion site. Two different balloon
expandable stents of various lengths and diameters were
used for the basilar artery (BA) and MCA: 1) Driver
(Medtronic, Santa Rosa, CA) and 2) Flexmaster (JoMed
International, Helsinborg, Sweden). Deployment of a self-
expandable Precise nitinol stent (JoMed) in 5 patients or
Zilver (Cook) in 1 patient was performed for ICA occlusion.
Immediately after stent placement, all of the patients were
given an oral dose of clopidogrel (300 mg) and aspirin (325
mg) and were maintained on clopidogrel (75 mg/day) and
aspirin (325 mg/day). Clopidogrel therapy was discontinued
after 1 month, and patients were maintained on aspirin
indefinitely. 
Results
The clinical summary was listed in Table 1. The cause of
lesion in all patients was atherothrombotic occlusion with
underlying high-grade vascular stenosis. The mean age of
our study of five men and four women was 58±12 years
(range 34 to 71 years). The median baseline NIHSS score
was 15 (range 12 to 20) and mean time to treatment was 9.8
±14.6 hours from symptom onset. Five lesions were located
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in the ICA, two were in the MCA, one was in the common
carotid artery, and one was in the mid-BA. Intravenous
tirofiban was administered in three of nine (33%) patients.
Intra-arterial thrombolysis was performed with urokinase in
six patients, and t-PA in three patients, and abciximab in one
patient. Balloon angioplasty was performed in seven
patients. All patients underwent successful crossing of the
occlusion site and subsequent stent angioplasty. The stenotic
ratio was reduced from 91% (pre-stenting) to 5% (post-
stenting) on average. Procedure-related complications
occurred in two patients (22%): distal embolism in one and
subacute thrombotic occlusion in the other. Seven of nine
patients (78%) exhibited a dramatic clinical improvement in
their NIHSS score at discharge. However, the complicated
two patients showed severe disabilities and their NIHSS
scores at discharge were similar to one on admission. At
discharge, median NIHSS score was 9 (range 5 to 18). These
results showed statistically significant clinical improvement
(P <0.05, Wilcoxon rank sum test). 
Discussion
This report with the preliminary results demonstrates that
stent angioplasty can be utilized as an option for patients
with lesions recalcitrant to pharmacological and mechanical
thrombolysis in acute athrothrombotic stroke. In addition,
this intervention may also improve survival and reduce
morbidity by restoration of blood flow to penumbral areas
and decreasing stroke volume. The lack of a control or
alternative treatment group does not allow us to assess
whether this approach is clinically beneficial but does
provide pilot data for subsequent study. 
Intra-arterial thrombolysis provides an alternative to
intravenous thrombolysis in selected patients with acute
ischemic stroke. Rapid, local delivery of fibrinolytic agents
or immediate access of thrombolytic devices is now feasible
with recent advances in the field of neurointervention. Intra-
arterial thrombolysis has been used most successfully in
patients with acute MCA occlusion. There is evidence that
the treatment window for intra-arterial thrombolysis can be
extended to at least 6 hours from stroke onset in patients
with MCA occlusion. Other potential candidates for intra-
arterial candidates for intra-arterial thrombolysis include
patients with extracranial ICA occlusion, intracranial ICA
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“T” occlusion, or basilar artery occlusion. Two randomized,
multicenter, controlled trials of intra-arterial thrombolysis in
acute MCA stroke have been reported so far, the Prolyse in
Acute Cerebral Thromboembolism Trial (PROACT-I) and
PROACT-II.4)7) PROACT-II study revealed that
recanalization rates of 66% in the treatment group versus
18% in the control group (P<0.001).7) Conversely,
symptomatic hemorrhage occurred in 10% of the
prourokinase group versus 2% in the control group.  In
PROACT-II, despite the higher early symptomatic
intracranial hemorrhage rate, patients overall benefited from
therapy, and there was no excess mortality (prourokinase
group 24%, control group 27%) in the “intention-to-treat”
analysis. The major issues with intra-arterial thrombolysis
has been the rate of hemorrhage, inability to effectively
dissolve platelet-rich clots, and lengthy times to
recanalization.3)7) Mechanical device trials were initiated in
the hopes of addressing these concerns. Mechanical
thrombolysis have included clot maceration with the
microcatheter or microwire, thrombus or embolus removal,
intra-arterial ultrasound, and balloon angioplasty.2)8)14)15)17) In
the Mechanical Embolus Removal in Cerebral Ischemia
(MERCI) phase I trial, successful recanalization was
demonstrated in cerebral vessels in 18 (64%) patients with or
without intra-arterial t-PA therapy.8) Sorimachi et al. reported
the recanalization rate was 46% using the Merci clot
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Fig. 1. Patient 1 presented with left hemiparesis 48 hours from stroke attack. A : Angiogram revealed complete occlusion of the right
middle cerebral artery. B : Severe stenosis appeared on angiogram obtained immediately after pharmacological and balloon
angioplasty. Blood flow was very weak through the stenosis. C : After satisfactory and uneventful stent deployment, angiogram showed
a normal caliber of the right middle cerebral artery.
Fig. 2. Patient 3 presented with right hemiparesis and mental change 5 hours from stroke attack. A : A diagnostic angiogram
confirmed the presence of a left carotid occlusion at the bifurcation. B : The occlusion was crossed with a 0.014-inch microwire and
microcatheter injection confirmed severe stenosis at the occlusion site. C : Poststenting and angioplasty revealed a normal caliber
left carotid and patent intracranial circulation.
retriever.17) Mechanical thrombolysis may reduce the need for
incremental doses of thrombolytics, thus minimizing the
hemorrhage risk. To date, there is insufficient evidence to
suggest a dose threshold at which hemorrhagic transformation
occurs. 
In most instances of acute vascular occlusions, the cause is
embolic in the absence of an underlying vascular stenosis.
However, plaque rupture in an underlying stenosis lead to
acute vascular occlusions. In our series with an underlying
vascular stenosis and acute thrombotic occlusion,
angioplasty was found to have temporary recanalizing effect
and thrombosis and reocclusion recurred during the
angioplasty. An occlusive lesion consisting of thrombus
superimposed on atherosclerotic plaque is more vulnerable
to reocclusion.16) Dissolution of the thrombus leads to
exposure of the thrombogenic plaque surface, thereby
providing a template for the reformation of thrombus.
Theoretically, stenting minimizes the risk of acute closure by
compression of the intimal flap, or trapping plaque material
between the stent and the vessel wall. Therefore, it is
considered stenting is better tool for vascular recanalization
than mechanical angioplasty. In the setting of acute
myocardial infarction, stenting began to replace angioplasty
as the primary means of revascularization for acute coronary
syndrome.10)18)21) In one multicenter, randomized trial
comparing stenting with angioplasty for acute myocardial
infarction, implantation of a stent has clinical benefits
beyond those of angioplasty alone.9) There have been several
reports about stent-assisted recanalization for acute stroke.6)11-
13)19) These reports concluded that stent-assisted
recanalization for acute stroke resulting from
atherothrombotic occlusion is associated with a high
recanalization rate and low intracranial hemorrhage rate.
These preliminary results suggest that stenting may be an
alternative option for recalcitrant cerebral artery occlusions.
However, they have limitations largely derived from its
retrospective nature. Future prospective studies are
necessary to determine which patients are most likely to
benefit from this form of therapy.
Problems about stenting are vessel rupture, dissection,
reperfusion hemorrhage, distal embolism, or subacute
occlusion. We experienced two complicated cases; distal
embolism and subacute occlusion. These risks can be
minimized by limiting the time from onset to revascularization
to limit reperfusion injury, by using experienced operators to
reduce the risk of vessel dissection, by maintaining
thrombolytic or antithrombotic therapy for several days to
prevent subacute occlusion, and by using devices to prevent
distal embolization. In addition, there is the longer-term risk
of stent restenosis, although this is less concerning given that
patients are being treated for a disease with a high
probability of severe disability and mortality.
Conclusions
Our preliminary results suggest that stent-assisted
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Fig. 3. Patient 8 presented with mental change 2 hours from stroke attack. The patient had known medical history of basilar artery
stenosis. A : A diagnostic angiogram confirmed the complete occlusion of mid basilar artery. B : After pharmacological thrombolysis,
moderate to severe stenosis was identified on mid-basilar portion. C : Poststenting and angioplasty showed a complete
recanalization of the stenotic basilar artery.
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recanalization for acute atherothrombotic stroke with an
underlying vessel stenosis were fairly good from the
viewpoints of clinical and angiographic follow-up results.
This procedure can be considered an alternative to
pharmacological and mechanical thrombolysis in selected
patients.
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